Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2006 2
2007 5
2008 3
2009 4
2010 4
2011 3
2012 3
2013 2
2014 14
2015 8
2016 4
2017 2
2018 6
2019 10
2020 22
2021 17
2022 10
2023 15
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Harris PNA, et al. Among authors: yilmaz m. JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. JAMA. 2018. PMID: 30208454 Free PMC article. Clinical Trial.
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2).
Stewart AG, Paterson DL, Young B, Lye DC, Davis JS, Schneider K, Yilmaz M, Dinleyici R, Runnegar N, Henderson A, Archuleta S, Kalimuddin S, Forde BM, Chatfield MD, Bauer MJ, Lipman J, Harris-Brown T, Harris PNA; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Stewart AG, et al. Among authors: yilmaz m. Open Forum Infect Dis. 2021 Aug 2;8(8):ofab387. doi: 10.1093/ofid/ofab387. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34395716 Free PMC article.
Switch to oral antibiotics in Gram-negative bacteraemia: a randomized, open-label, clinical trial.
Omrani AS, Abujarir SH, Ben Abid F, Shaar SH, Yilmaz M, Shaukat A, Alsamawi MS, Elgara MS, Alghazzawi MI, Shunnar KM, Zaqout A, Aldeeb YM, Alfouzan W, Almaslamani MA; SOAB Study Group. Omrani AS, et al. Among authors: yilmaz m. Clin Microbiol Infect. 2024 Apr;30(4):492-498. doi: 10.1016/j.cmi.2023.10.014. Epub 2023 Oct 18. Clin Microbiol Infect. 2024. PMID: 37858867 Clinical Trial.
Visual vignette.
Arslan F, Karagoz E, Yılmaz M, Mert A. Arslan F, et al. Among authors: yilmaz m. Endocr Pract. 2015 Mar;21(3):299. doi: 10.4158/EP14507.VV. Endocr Pract. 2015. PMID: 25536974 No abstract available.
Nivolumab-induced lichen planus.
Yilmaz M, Mese SG, Celik U. Yilmaz M, et al. J Oncol Pharm Pract. 2020 Apr;26(3):758-760. doi: 10.1177/1078155219866248. Epub 2019 Aug 5. J Oncol Pharm Pract. 2020. PMID: 31382865
Hepatic granulomas: etiologic distribution.
Mert A, Yılmaz M, Ceylan B, Aslan F. Mert A, et al. Among authors: yilmaz m. Turk J Gastroenterol. 2014 Oct;25(5):529-30. doi: 10.5152/tjg.2014.0052. Turk J Gastroenterol. 2014. PMID: 25417614 Free article. No abstract available.
Lutetium-Associated Myopathy: A Case Report.
Gulturk I, Sonmezoz GB, Yilmaz M, Tacar SY, Ozmen A, Erdal GS, Nalbant MO, Tural D. Gulturk I, et al. Among authors: yilmaz m. Am J Ther. 2024 Jan-Feb 01;31(1):e81-e84. doi: 10.1097/MJT.0000000000001491. Epub 2022 Mar 24. Am J Ther. 2024. PMID: 35383588 No abstract available.
Prospective analysis of febrile neutropenia patients with bacteraemia: the results of an international ID-IRI study.
Erdem H, Kocoglu E, Ankarali H, El-Sokkary R, Hakamifard A, Karaali R, Kulzhanova S, El-Kholy A, Tehrani HA, Khedr R, Kaya-Kalem A, Pandak N, Cagla-Sonmezer M, Nizamuddin S, Berk-Cam H, Guner R, Elkholy JA, Llopis F, Marino A, Stebel R, Szabo BG, Belitova M, Fadel E, Yetisyigit T, Cag Y, Alkan S, Kayaaslan B, Oncu S, Ozdemir M, Yilmaz M, Isik AC, Başkol D, Sincan G, Cascio A, Ozer-Balin S, Korkmaz N, Ripon RK, Abbas S, Dumitru IM, Eser-Karlidag G, Lanzafame M, Rafey A, Raza A, Sipahi OR, Darazam IA, Elbahr U, Erdem I, Ergen P, Bilir C, Caskurlu H, Erdem A, Makek MJ, Altindis M, Lakatos B, Luca CM, Yilmaz EM, Nsutebu E, Cakmak R, Sirmatel F. Erdem H, et al. Among authors: yilmaz m. Int J Antimicrob Agents. 2023 Sep;62(3):106919. doi: 10.1016/j.ijantimicag.2023.106919. Epub 2023 Jul 7. Int J Antimicrob Agents. 2023. PMID: 37423582
Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study.
Aslan AT, Tabah A, Köylü B, Kalem AK, Aksoy F, Erol Ç, Karaali R, Tunay B, Guzeldağ S, Batirel A, Dindar EK, Akdoğan Ö, Bilir Y, Ersöz G, Öztürk B, Selçuk M, Yilmaz M, Akyol A, Akbaş T, Sungurtekin H, Timuroğlu A, Gürbüz Y, Çolak O, Bayindir Y, Eroğlu A, Ferlicolak L, Çeşme U, Dağ O, Buetti N, Barbier F, Ruckly S, Staiquly Q, Timsit JF, Akova M. Aslan AT, et al. Among authors: yilmaz m. J Antimicrob Chemother. 2023 Jul 5;78(7):1757-1768. doi: 10.1093/jac/dkad167. J Antimicrob Chemother. 2023. PMID: 37264485 Free PMC article.
122 results